United States · FDA National Drug Code directory
BIOFREEZE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59316-102_51b44481-a7ad-8a46-e063-6294a90aefda
- Product NDC
- 59316-102
- Form
- GEL
- Composition / generic term
- MENTHOL
- Labeler
- Reckitt Benckiser LLC
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20120103
- Source listing expiry
- 20271231
Source-listed ingredients
- MENTHOL, UNSPECIFIED FORM — 40 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 mL in 1 BOTTLE (59316-102-10) · 59316-102-10
- 3 mL in 1 BOTTLE (59316-102-11) · 59316-102-11
- 89 mL in 1 BOTTLE (59316-102-12) · 59316-102-12
- 118 mL in 1 BOTTLE (59316-102-20) · 59316-102-20
- 237 mL in 1 BOTTLE (59316-102-28) · 59316-102-28
- 473 mL in 1 BOTTLE (59316-102-30) · 59316-102-30
- 946 mL in 1 BOTTLE (59316-102-40) · 59316-102-40
- 3785 mL in 1 CONTAINER (59316-102-50) · 59316-102-50
- 44 mL in 1 TUBE (59316-102-80) · 59316-102-80
- 100 BOTTLE in 1 CARTON (59316-102-90) / 5 mL in 1 BOTTLE (59316-102-10) · 59316-102-90
- 30 mL in 1 BOTTLE (59316-102-98) · 59316-102-98
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →